Magazine Article | February 1, 2023

Clinical Manufacturing Volume By Service Provider Category

Source: Life Science Leader

By Industry Standard Research

When it comes to outsourced clinical manufacturing, respondents allocate the largest proportion of project volume to A combination of drug substance and drug product CDMOs (41%). Close behind, Global, Full-Service, One-Stop-Shop CDMOs account for 37% of survey participants’ clinical manufacturing project volume. Over the next three years, respondents anticipate shifting some project work from A combination of drug substance and drug product CDMOs to Global, Full-Service, One-Stop-Shop CDMOs, bringing that category of provider’s volume in line with respondents’ overall preference.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader